Image Ben Hargreaves Digital Why healthcare is an easy target for cyberattacks The healthcare industry is getting hit more and more frequently by ransomware attacks. R&D Psychedelic treatments on cusp of approval, but questions re... There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy. Digital Women’s health and digital tech empowerment Digital health tools have become a staple in many people’s efforts to stay healthy, not least during the pandemic. R&D R&D in 2023 sees focus return to oncology After the rush of research to find solutions to the pandemic, a recent report has found that pharma R&D has returned to its usual rhythms. Load more results
Digital Why healthcare is an easy target for cyberattacks The healthcare industry is getting hit more and more frequently by ransomware attacks.
R&D Psychedelic treatments on cusp of approval, but questions re... There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy.
Digital Women’s health and digital tech empowerment Digital health tools have become a staple in many people’s efforts to stay healthy, not least during the pandemic.
R&D R&D in 2023 sees focus return to oncology After the rush of research to find solutions to the pandemic, a recent report has found that pharma R&D has returned to its usual rhythms.
R&D Reuters Pharma USA 2024 – Meruno Perugini Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.